市场调查报告书

核酸标签的全球市场 - 成长,趋势,预测(2018年~2023年)

Nucleic Acid Labeling Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品编码 708649
出版日期 内容资讯 英文 120 Pages
商品交期: 2-3个工作天内
价格
Back to Top
核酸标签的全球市场 - 成长,趋势,预测(2018年~2023年) Nucleic Acid Labeling Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日内容资讯: 英文 120 Pages
简介

全球核酸标签市场在2018年到2023年间,预测将以9%的年复合成长率扩大。

本报告提供核酸标签的全球市场调查,提供市场概要,各类型,用途,各地区的市场趋势,市场规模的变化与预测,市场促进·阻碍因素以及市场机会分析,竞争情形,主要企业的简介等全面性资讯。

目录

第1章 简介

  • 市场定义

第2章 调查方法

第3章 摘要整理

第4章 主要影响要素

第5章 市场概要

  • 市场方案
  • 波特的五力分析
    • 供应商谈判力
    • 消费者谈判力
    • 新加入厂商的威胁
    • 替代产品与服务的威胁
    • 产业内的竞争

第6章 市场动态

  • 成长要素
  • 阻碍因素
  • 市场机会
  • 课题

第7章 市场区隔

  • 标签类别
    • 生物素系
    • 萤光
    • 放射性
    • 其他
  • 标签技术
    • 终端标签
    • 缺口平移
    • 随机启动
    • 体外转录
  • 各用途
    • 墨点法
    • 核酸定序
    • 光原位杂交法
    • 微阵列
    • PCR
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东·非洲
    • 南美

第8章 企业简介

  • Enzo Biochem Inc.
  • GE Healthcare
  • Marker Gene Technologies Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories Inc.

第9章 市场未来展望

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 64284

Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, which has become popular in recent years. Healthcare technology, genomics involving nucleic acid labeling technology, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses and make more informed treatment decisions. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies must be developed, which, in turn, has resulted in the rapid expansion of the market. Therefore, increasing focus on personalized medicine and patient-centered approach is driving the growth of the nucleic acid labeling market.

Key Market Trends

Biotin Based Segment is Expected to Show Better Growth Over the Forecast Period

Based on label type, the market is segmented into biotin-based, fluorescent, radioactive and other label types. Non-radioactively labeled probes, such as biotin-based probes have several advantages over radioactive probes, such as increased stability and their non-hazardous nature. The biotin-based labels use non-toxic materials and have faster detection rates than radioactive probes. Furthermore, owing to their long half-life and high stability, biotin-based probes can be prepared in bulk and stored at -20°C for repeated uses. Furthermore, there have been several advancements in biotin-based techniques, such as the addition of long tails of biotinylated nucleotides through enzymatic methods to counter the technique's limitations. Pertaining to these advancements, the biotin-based label segment is expected to show better growth during the forecast period.

North America is Expected to Dominate the Nucleic Acid Labeling Market

The nucleic acid labeling market dominates the North America region due to the increasing prevalence of chronic diseases, such as cancer, aging population, growing demand for targeted and personalized medicine, and favorable government initiatives. In recent years, several government initiatives have been launched, which is supplementing the growth of the nucleic acid labeling market in the United States. For instance, in 2015, the Precision Medicine Initiative was introduced to revolutionize the treatment of chronic diseases, which has accelerated the growth of the nucleic acid labeling and its acceptance as well as adoption in the region.

Competitive Landscape

The global players into the nucleic acid labeling market are Enzo Biochem Inc., GE Healthcare, Marker Gene Technologies Inc., Merck KGaA, New England Biolabs Inc., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific and Vector Laboratories Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Genomic and Enzymology Research
    • 4.2.2 Advancements in Tools for Synthetic Genome Design
    • 4.2.3 Growing Demand for Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 High Cost and Complexity of Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Label Type
    • 5.1.1 Biotin-based
    • 5.1.2 Fluorescent
    • 5.1.3 Radioactive
    • 5.1.4 Other Label Types
  • 5.2 By Application
    • 5.2.1 Microarray
    • 5.2.2 DNA Sequencing
    • 5.2.3 In situ Hybridization
    • 5.2.4 Polymerase Chain Reaction
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals/Clinics
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Enzo Biochem Inc.
    • 6.1.2 GE Healthcare
    • 6.1.3 Marker Gene Technologies Inc.
    • 6.1.4 Merck KGaA
    • 6.1.5 New England Biolabs Inc.
    • 6.1.6 PerkinElmer Inc.
    • 6.1.7 Promega Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Vector Laboratories Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top